June 29, 2020 / 7:03 AM / 6 days ago

BRIEF-Luye Pharma Group Says Clinical Trial Application Of Lurbinected Accepted By CDE Of PRC

June 29 (Reuters) - Luye Pharma Group Ltd:

* CLINICAL TRIAL APPLICATION OF LURBINECTEDIN FOR INJECTION (LY01017) ACCEPTED BY CENTRE FOR DRUG EVALUATION OF PRC Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below